DekaBank Deutsche Girozentrale
KITE

DekaBank Deutsche Girozentrale’s Kite Pharma, Inc. KITE Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio KITE Stock Details KITE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-16,650
Closed -$2.13M – 1040
2017
Q3 		$2.13M Hold
16,650
– – 0.02% 541
2017
Q2 		$1.71M Sell
16,650
-15,000
-47% -$1.22M 0.01% 576
2017
Q1 		$2.48M Sell
31,650
-18,900
-37% -$1.17M 0.02% 456
2016
Q4 		$2.34M Sell
50,550
-39,400
-44% -$1.93M 0.02% 430
2016
Q3 		$5.04M Sell
89,950
-53,000
-37% -$2.95M 0.06% 301
2016
Q2 		$7.29M Buy
142,950
+119,100
+499% +$5.85M 0.08% 245
2016
Q1 		$1.05M Buy
23,850
+1,600
+7% +$77.5K 0.01% 540
2015
Q4 		$1.39M Buy
22,250
+600
+3% +$42.2K 0.02% 515
2015
Q3 		$1.21M Buy
21,650
+950
+5% +$59.8K 0.01% 528
2015
Q2 		$1.26M Buy
20,700
+2,700
+15% +$154K 0.02% 521
2015
Q1 		$1.04M Buy
+18,000
New +$1.21M 0.01% 569

DekaBank Deutsche Girozentrale's KITE Position: Q4 2017 in Review

DekaBank Deutsche Girozentrale sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 16,650 shares — an estimated $2.13M sold.

DekaBank Deutsche Girozentrale first reported a position in KITE in Q1 2015 and held it in 11 quarters. The position peaked at $7.29M in Q2 2016. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.

  • DekaBank Deutsche Girozentrale reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
  • DekaBank Deutsche Girozentrale sold 16,650 Kite Pharma, Inc. shares in Q4 2017, an estimated $2.13M.
  • DekaBank Deutsche Girozentrale first reported a position in Kite Pharma, Inc. in Q1 2015 and held it in 11 quarters.
  • DekaBank Deutsche Girozentrale's Kite Pharma, Inc. position peaked at $7.29M in Q2 2016.
  • 0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q4 2017, filed 14 Feb 2018.